
EOB-DTPA
CAS No. 158599-72-5
EOB-DTPA( —— )
Catalog No. M36120 CAS No. 158599-72-5
EOB-DTPA is a biochemical reagent that can be synthesized from other compounds and is commonly used in MRI.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 445 | Get Quote |
![]() ![]() |
5MG | 698 | Get Quote |
![]() ![]() |
10MG | 938 | Get Quote |
![]() ![]() |
25MG | 1422 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
100MG | 2502 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEOB-DTPA
-
NoteResearch use only, not for human use.
-
Brief DescriptionEOB-DTPA is a biochemical reagent that can be synthesized from other compounds and is commonly used in MRI.
-
DescriptionEOB-DTPA is a biochemical reagent that can be synthesized from other compounds and is commonly used in MRI.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number158599-72-5
-
Formula Weight527.52
-
Molecular FormulaC23H33N3O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](N(CC(O)=O)CC(O)=O)(CC1=CC=C(OCC)C=C1)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Fenpyroximate
Fenpyroximate is an acaricide and insecticide. It blocks the mitochondrial electron transport in complex I.
-
SMA-12b
SMA-12b is an analog of the immunomodulatory parasite product ES-62 that has immunomodulatory activity, can modify the expression of many inflammatory response genes.
-
FIDAS-5
FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding.?FIDAS-5 has anticancer activities.?FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM.FIDAS-5 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells.